Top Section/Ad
Top Section/Ad
Most recent
◆ Italy dazzles with size as we launch our new MTN Awards ◆ Enel snubs the market it created ◆ Record month for CEEMEA bond issuers
European sovereign pair showcased the value of the MTN market
Chunky collared FRN expands sovereign's private funding for the year to €4bn
Major corporates pile into short end of the private placement market
More articles/Ad
More articles/Ad
More articles
-
A technical issue around the data submission meant that the euro area short term rate (€STR) did not have enough data to be calculated in the usual way this morning, forcing the ECB to use its contingency method. -
Although the MTN market contracted during the first half of 2020, structured issuance rose. The bulk of the increase came in the form of notes with calls added to enhance yield.
-
Issuers have been flocking to the market with coronavirus response bonds, but only a few have sold MTNs with the same theme. That is changing however, and IDB Invest, the private sector investment arm of the Inter-American Development Bank is likely to be next.
-
TD Securities has appointed Matthew Jaconelli to head up its MTN and niche currency operations in Europe, taking over from Sameer Rehman, who will now focus on financial and corporate issuance.
-
Euro investors are sniffing around further out along the SSA curve, with Euratom returning after a two year absence to print a 10 year bond earmarked to fund power plant safety measures in Ukraine, while the Treasury Corp of Victoria tapped demand past the 30 year point.
-
The International Finance Facility for Immunisation (IFFIm) was set up in 2006 to provide funding to Gavi, the Vaccine Alliance, itself a public/private sector partnership, to expedite the vaccination of children in the poorest countries against endemic infectious diseases. Doris Herrera-Pol, IFFIm board member and former director of global capital markets at the World Bank, spoke to GlobalCapital about the role the capital markets can play in the development and deployment of a Covid-19 vaccine.
